Coverage
-
February 07, 2014
Myriad Genetics Inc. has settled its suit against Gene by Gene Ltd. over alleged infringement of its cancer-testing patents, including several that were upheld in a landmark U.S. Supreme Court decision last year, with Gene by Gene agreeing to stop offering the tests in North America, the companies said Friday.
3 other articles on this case.
View all »